Cargando…

Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19–25 nucleotides that are involved in regulating a range of developmental and physiological processes. Non-exosomal circulating and exosomal miRNAs have also been proposed to be useful in diagnostics as biomarkers for diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Nik Mohamed Kamal, Nik Nur Syazana Binti, Shahidan, Wan Nazatul Shima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984169/
https://www.ncbi.nlm.nih.gov/pubmed/32038230
http://dx.doi.org/10.3389/fphar.2019.01500
_version_ 1783491610020937728
author Nik Mohamed Kamal, Nik Nur Syazana Binti
Shahidan, Wan Nazatul Shima
author_facet Nik Mohamed Kamal, Nik Nur Syazana Binti
Shahidan, Wan Nazatul Shima
author_sort Nik Mohamed Kamal, Nik Nur Syazana Binti
collection PubMed
description MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19–25 nucleotides that are involved in regulating a range of developmental and physiological processes. Non-exosomal circulating and exosomal miRNAs have also been proposed to be useful in diagnostics as biomarkers for diseases and different types of cancer. In this review, the quantity of miRNAs and of reliable experimental data analyses of miRNAs that come from exosomal and non-exosomal sources are discussed from the perspective of their use as biomarkers for cancer and other diseases, including viral infections, nervous system disorders, cardiovascular disorders, and diabetes. We summarize other research findings regarding the use of miRNA from these two sources as biomarkers in diagnostics and clinical use. The challenges in using miRNA from these two sources in cancer and disease diagnostics are evaluated and discussed. Validation of specific miRNA signatures as biomarkers is a critical milestone in diagnostics.
format Online
Article
Text
id pubmed-6984169
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69841692020-02-07 Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers? Nik Mohamed Kamal, Nik Nur Syazana Binti Shahidan, Wan Nazatul Shima Front Pharmacol Pharmacology MicroRNAs (miRNAs) are a group of small non-coding RNAs with approximately 19–25 nucleotides that are involved in regulating a range of developmental and physiological processes. Non-exosomal circulating and exosomal miRNAs have also been proposed to be useful in diagnostics as biomarkers for diseases and different types of cancer. In this review, the quantity of miRNAs and of reliable experimental data analyses of miRNAs that come from exosomal and non-exosomal sources are discussed from the perspective of their use as biomarkers for cancer and other diseases, including viral infections, nervous system disorders, cardiovascular disorders, and diabetes. We summarize other research findings regarding the use of miRNA from these two sources as biomarkers in diagnostics and clinical use. The challenges in using miRNA from these two sources in cancer and disease diagnostics are evaluated and discussed. Validation of specific miRNA signatures as biomarkers is a critical milestone in diagnostics. Frontiers Media S.A. 2020-01-20 /pmc/articles/PMC6984169/ /pubmed/32038230 http://dx.doi.org/10.3389/fphar.2019.01500 Text en Copyright © 2020 Nik Mohamed Kamal and Shahidan http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Nik Mohamed Kamal, Nik Nur Syazana Binti
Shahidan, Wan Nazatul Shima
Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
title Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
title_full Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
title_fullStr Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
title_full_unstemmed Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
title_short Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
title_sort non-exosomal and exosomal circulatory micrornas: which are more valid as biomarkers?
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984169/
https://www.ncbi.nlm.nih.gov/pubmed/32038230
http://dx.doi.org/10.3389/fphar.2019.01500
work_keys_str_mv AT nikmohamedkamalniknursyazanabinti nonexosomalandexosomalcirculatorymicrornaswhicharemorevalidasbiomarkers
AT shahidanwannazatulshima nonexosomalandexosomalcirculatorymicrornaswhicharemorevalidasbiomarkers